p.H768Q | TCGA-39-5021 | LUSC | TCGA | KKVLHAE | LIG_APCC_ABBAyCdc20_2 | 764:770 | Mutation altering degron motif | 0.7582 |
p.H768Q | TCGA-CR-7371 | HNSC | TCGA | KKVLHAE | LIG_APCC_ABBAyCdc20_2 | 764:770 | Mutation altering degron motif | 0.7582 |
p.H768Q | DO15454 | HNSC | ICGC | KKVLHAE | LIG_APCC_ABBAyCdc20_2 | 764:770 | Mutation altering degron motif | 0.7582 |
p.H768Q | DO27397 | LUSC | ICGC | KKVLHAE | LIG_APCC_ABBAyCdc20_2 | 764:770 | Mutation altering degron motif | 0.7582 |
p.R778G | TCGA-49-4507 | LUAD | TCGA | KKVLHAE | LIG_APCC_ABBAyCdc20_2 | 764:770 | Mutation rewiring degron network | 0.1111 |
p.R778G | DO25727 | LUAD | ICGC | KKVLHAE | LIG_APCC_ABBAyCdc20_2 | 764:770 | Mutation rewiring degron network | 0.1111 |
p.V761A | TCGA-AG-A002 | READ | TCGA | KKVLHAE | LIG_APCC_ABBAyCdc20_2 | 764:770 | Mutation rewiring degron network | 0.25 |
p.S757P | TCGA-B5-A0K6 | UCEC | TCGA | KKVLHAE | LIG_APCC_ABBAyCdc20_2 | 764:770 | Mutation rewiring degron network | 0.1389 |
p.S757P | DO40808 | UCEC | ICGC | KKVLHAE | LIG_APCC_ABBAyCdc20_2 | 764:770 | Mutation rewiring degron network | 0.1389 |
p.W754S | TCGA-BT-A20T | BLCA | TCGA | KKVLHAE | LIG_APCC_ABBAyCdc20_2 | 764:770 | Mutation rewiring degron network | 0.0556 |
p.W754S | DO804 | BLCA | ICGC | KKVLHAE | LIG_APCC_ABBAyCdc20_2 | 764:770 | Mutation rewiring degron network | 0.0556 |
p.W754G | TCGA-D3-A2JH | SKCM | TCGA | KKVLHAE | LIG_APCC_ABBAyCdc20_2 | 764:770 | Mutation rewiring degron network | 0.0556 |
p.W754G | DO47263 | SKCM | ICGC | KKVLHAE | LIG_APCC_ABBAyCdc20_2 | 764:770 | Mutation rewiring degron network | 0.0556 |
p.A769S | TCGA-MA-AA3W | CESC | TCGA | KKVLHAE | LIG_APCC_ABBAyCdc20_2 | 764:770 | Mutation altering degron motif | 0.6477 |
p.A769S | DO219719 | CESC | ICGC | KKVLHAE | LIG_APCC_ABBAyCdc20_2 | 764:770 | Mutation altering degron motif | 0.6477 |
p.A769T | SIDM00121 | T-Lymphoblastic Leukemia | GDSC | KKVLHAE | LIG_APCC_ABBAyCdc20_2 | 764:770 | Mutation altering degron motif | 0.6028 |
p.A769T | SIDM01089 | B-Cell Non-Hodgkin's Lymphoma | GDSC | KKVLHAE | LIG_APCC_ABBAyCdc20_2 | 764:770 | Mutation altering degron motif | 0.6028 |
p.A769T | ACH-000371 | Lymphoma | CCLE | KKVLHAE | LIG_APCC_ABBAyCdc20_2 | 764:770 | Mutation altering degron motif | 0.6028 |
p.A769T | ACH-001738 | Leukemia | CCLE | KKVLHAE | LIG_APCC_ABBAyCdc20_2 | 764:770 | Mutation altering degron motif | 0.6028 |
p.A769T | CCRF-CEM | haematopoietic and lymphoid tissue | COSMIC | KKVLHAE | LIG_APCC_ABBAyCdc20_2 | 764:770 | Mutation altering degron motif | 0.6028 |
p.A769T | RL | haematopoietic and lymphoid tissue | COSMIC | KKVLHAE | LIG_APCC_ABBAyCdc20_2 | 764:770 | Mutation altering degron motif | 0.6028 |
p.H768Y | ACH-002041 | Thyroid Cancer | CCLE | KKVLHAE | LIG_APCC_ABBAyCdc20_2 | 764:770 | Mutation altering degron motif | 0.6118 |